Christian Jonasson

Norwegian University of Science and Technology, Norway

Disclosure information not submitted.

Presentation(s):

• Glucagon-like Peptide 1 Receptor Agonist Use and Risk of Thyroid Cancer: Scandinavian Cohort Study

  Tuesday, August 27, 2024
  9:00 AM – 9:15 AM CEST

• Hypothetical target trial to compare the effectiveness of atezolizumab, pembrolizumab and nivolumab in second line treatment of advanced non-small cell lung cancer

  Tuesday, August 27, 2024
  2:15 PM – 2:30 PM CEST

• Comparative cardiovascular and renal effectiveness of empagliflozin and dapagliflozin: Scandinavian cohort study

  Wednesday, August 28, 2024
  9:30 AM – 9:45 AM CEST